Literature DB >> 9746735

Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro.

U A Vitt1, H J Kloosterboer, U M Rose, J W Mulders, P S Kiesel, S Bete, P L Nayudu.   

Abstract

The effects of three isoforms derived from recombinant human FSH on ovarian follicle development in vitro were characterized for the first time. The three subfractions comprised discrete pI ranges of 3. 6-4.6 (acid), 4.5-5.0 (mid), and 5.0-5.6 (least acidic). Follicular growth, estradiol secretion, and antral formation were assessed for each fraction of isoforms in a range of concentrations over a 5-day culture period. Least acidic FSH produced, at and above 1.5 ng/ml, a high percentage of follicles growing above the size threshold necessary for antral formation, whereas mid and acid FSH induced similar growth only at higher concentrations (7.5 ng/ml and 50 ng/ml, respectively). Least acidic FSH specifically induced the most rapid growth of follicles during preantral development. Acid FSH at all concentrations stimulated estradiol-17ss secretion later during culture and antral formation in a lower proportion of follicles than did least acidic and mid FSH. It can be concluded 1) that the least acidic isoform induced fastest preantral growth, producing the largest antral follicles at the lowest dose of all three fractions and 2) that the less and mid acidic isoforms had more impact on stimulation of estradiol production and antral formation than the acid isoform.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746735     DOI: 10.1095/biolreprod59.4.854

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  12 in total

1.  In vitro follicle growth under non-attachment conditions and decreased FSH levels reduces Lhcgr expression in cumulus cells and promotes oocyte developmental competence.

Authors:  Flor Sánchez; Sergio Romero; Firas K Albuz; Johan Smitz
Journal:  J Assist Reprod Genet       Date:  2011-12-22       Impact factor: 3.412

2.  Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1.

Authors:  Mianmian Yin; Mingrong Lü; Guidong Yao; Hui Tian; Jie Lian; Lin Liu; Meng Liang; Yong Wang; Fei Sun
Journal:  Mol Endocrinol       Date:  2012-05-16

3.  Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.

Authors:  Arianna Pacchiarotti; Cesare Aragona; Renzo Gaglione; Helmy Selman
Journal:  J Assist Reprod Genet       Date:  2007-07-26       Impact factor: 3.412

Review 4.  Follicle-Stimulating Hormone Glycobiology.

Authors:  George R Bousfield; David J Harvey
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

5.  Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: clinical and biochemical (cumulus cell gene expression) aspects.

Authors:  Timur Gurgan; Debbie Montjean; Aygul Demirol; Yves J R Menezo
Journal:  J Assist Reprod Genet       Date:  2014-03-18       Impact factor: 3.412

Review 6.  Role of glycosylation in function of follicle-stimulating hormone.

Authors:  A Ulloa-Aguirre; C Timossi; P Damián-Matsumura; J A Dias
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

7.  Hypoglycosylated hFSH Has Greater Bioactivity Than Fully Glycosylated Recombinant hFSH in Human Granulosa Cells.

Authors:  Chao Jiang; Xiaoying Hou; Cheng Wang; Jeffrey V May; Viktor Y Butnev; George R Bousfield; John S Davis
Journal:  J Clin Endocrinol Metab       Date:  2015-04-27       Impact factor: 5.958

8.  Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins.

Authors:  Mianmian Yin; Xiaorong Wang; Guidong Yao; Mingrong Lü; Meng Liang; Yingpu Sun; Fei Sun
Journal:  J Biol Chem       Date:  2014-05-14       Impact factor: 5.157

9.  Promoting extracellular matrix remodeling via ascorbic acid enhances the survival of primary ovarian follicles encapsulated in alginate hydrogels.

Authors:  David Tagler; Yogeshwar Makanji; Tao Tu; Beatriz Peñalver Bernabé; Raymond Lee; Jie Zhu; Ekaterina Kniazeva; Jessica E Hornick; Teresa K Woodruff; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2014-01-22       Impact factor: 4.530

10.  Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus.

Authors:  Raoul Orvieto; Christos A Venetis; Human M Fatemi; Thomas D'Hooghe; Robert Fischer; Yulia Koloda; Marcos Horton; Michael Grynberg; Salvatore Longobardi; Sandro C Esteves; Sesh K Sunkara; Yuan Li; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.